Navigation Links
GlaxoSmithKline’s Tykerb is to Be Started Earlier in Breast Cancer, Study Find

London: Statistics from a Phase III study has shown that GlaxoSmithKline's Tykerb along with Roche's Xeloda is far better than Xeloda alone in women with HER2// positive advanced breast cancer, where the disease had progressed despite previous therapy involving Herceptin.

Basis the findings, researchers opined that, Tykerb should be checked out for its use during the early treatment of HER2 positive breast cancer.

"Patients with advanced or metastatic HER2 positive breast cancer have limited options once their cancer has progressed on trastuzumab and standard initial chemotherapy regimens. There has been a clear need for alternative treatments to help women with metastatic breast cancer in this advanced setting. Lapatinib combined with capecitabine has demonstrated superior efficacy over capecitabine alone in this group of patients and we look forward to it being made available to women suffering from this devastating disease," said lead investigator Charles Geyer, Director of Breast Medical Oncology at Allegheny General Hospital, Pittsburgh, Pennsylvania, U.S.

Women suffering HER2 positive breast cancer carry an enhanced risk of advancement of disease and death as against women suffering tumors.
'"/>




Page: 1

Related medicine news :

1. GlaxoSmithKline’s Epilepsy Drug given the Green Signal by FD
2. GSK Seeks Permission to Market Breast Cancer Pill Tykerb
3. International Osteoporosis Research Centre To Be Started In India.
4. New Test Can Detect Breast Cancer 8 Years Earlier
5. Earlier the better to start healthy diets
6. Gum Disease Affects Diabetic Children Earlier Than Anticipated
7. Earlier Introduction of Solid Foods in Infants Could Prevent Wheat Allergy
8. Earlier the Cochlear Implants Used Better the Speech
9. Profiling of Cancer Genes May Lead to Earlier Detection Human Cancers
10. Hay Fever Season may Begin Earlier, Warns Experts
11. Diabetes Risk Factors Develop Earlier in Women Than Men
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/27/2016)... ... 27, 2016 , ... An educational campaign aimed at everyone ... courtesy of awareness-driven celebrities and thought leaders. It also provides insight to the ... leaders such as Bioness. , As patients feel increasingly concerned about the ...
(Date:5/27/2016)... ... May 27, 2016 , ... Aimed at nurses and ... stories, which come courtesy of leaders in the nursing and health care industry. It ... advocates and associations—namely Abilene Christian University. , As the nursing industry is coming ...
(Date:5/26/2016)... ... ... There are many ways to cook a hot dog, but new research commissioned ... dogs straight off the grill. Of the 90 percent of Americans who say they ... hot dog, far outpacing other cooking methods such as steaming (12 percent), microwaving (9 ...
(Date:5/26/2016)... ... May 26, 2016 , ... ... (IP) to its specialty academic programs. , Answering to the increasing demand for ... programs in health law, and environmental and land use law. ,  , “The ...
(Date:5/26/2016)... ... May 26, 2016 , ... Cardiac arrhythmia is ... impact on long-term patient survival, reports a team of UPMC researchers in the ... in the Journal of Thoracic and Cardiovascular Surgery, provide critical information that will ...
Breaking Medicine News(10 mins):
(Date:5/27/2016)... , May 27, 2016 ... instances of hypertension is driving ambulatory blood pressure monitoring ... their elasticity and their ability to respond to different ... This condition can lead to various cardiovascular disorders such ... vascular disease. These diseases are growing in prevalence each ...
(Date:5/27/2016)... FRANCISCO , May 27, 2016 ... company focused on developing products for Regenerative Medicine, Neurology and Orphan ... will be presenting at two upcoming investor conferences: ... Center, 730 Third Avenue, New York City , ... 3:00pm Marcum MicroCap Conference   Where: ...
(Date:5/26/2016)... 26, 2016 A key trend ... the emergence of new treatments. Cardax, a development stage ... treatment. The therapy is expected to fulfil large unmet ... is conducting studies to develop new treatments for osteoarthritis. ... genes involved in osteoarthritis are being investigated, and early ...
Breaking Medicine Technology: